VivoSim Labs, INC.VIVSEarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
VivoSim Labs, Inc. is a preclinical biotechnology company that develops advanced human organ and tissue simulation platforms. Its products are used by pharmaceutical firms, contract research organizations, and academic institutions to evaluate drug safety, efficacy, and toxicity, reducing reliance on traditional animal testing in global life sciences research segments.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 1.5M | — | 2024-11-14 |
| Sumitomo Mitsui Trust Holdings, Inc. | 0.00% | 68.6K | — | 2024-02-05 |
| Nikko Asset Management Americas, Inc. | 0.00% | 11.6K | — | 2024-02-12 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.